Method for creating hyperpolarization at microtesla magnetic fields

ABSTRACT

Provided are methods for nuclear spin polarization enhancement via signal amplification by reversible exchange at very low magnetic fields.

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application No. 62/069,542, filed Oct. 28, 2014, which is herein incorporated by reference in its entirety.

STATEMENT OF GOVERNMENT INTEREST

This invention was made with government support under Awards No. CHE-1363008, CHE-1416268 and CHE-1416432 awarded by the National Science Foundation; Award No. 1R21EB018014 by the National Institute of Health; and Award No. W81WH-12-1-0159/BC112431 by the Department of Defense. The Government has certain rights in the invention.

TECHNICAL FIELD

The present disclosure relates to methods for nuclear spin polarization enhancement at very low magnetic fields (e.g., significantly lower than magnetic field of Earth of 50 microTesla) via signal amplification by reversible exchange.

BACKGROUND

Nuclear magnetic resonance (NMR) and magnetic resonance imaging (MM) sensitivity can be enhanced through hyperpolarization by temporarily increasing the relatively low nuclear spin polarization (P=10⁻⁶-10⁻⁵)—in some cases approaching unity—effectively providing 10⁴-10⁵-fold NMR signal enhancement. Despite the short-lived nature of hyperpolarized (HP) spin states, with typical lifetimes on the order of seconds for ¹H or minutes for heteronuclei (e.g., ¹⁵N, ¹³C), the considerable sensitivity gain has led to many biomedical applications where a given HP compound serves as injectable or inhalable contrast agent.

Current hyperpolarization methods for preparation of HP contrast agents include dissolution dynamic nuclear polarization (d-DNP). However, d-DNP is expensive, complex and not easily scalable. Another route to address the NMR/MRI sensitivity problem is the use of parahydrogen (abbreviated here as p-H₂ or para-H₂) as the hyperpolarization source, as is done in a family of techniques referred to collectively as Parahydrogen-Induced Polarization (PHIP). In traditional PHIP, molecular precursors with unsaturated chemical bonds are hydrogenated via molecular addition of para-H₂, thereby transferring the nuclear spin order to the molecular products. HP ¹³C molecules produced by this approach have been efficiently used as HP contrast agents in vivo.

In a more recent technique known as Signal Amplification by Reversible Exchange (SABRE), spin order may be transferred from para-H₂ to target molecules during the lifetime of transient molecular complexes without permanent chemical change. SABRE generally uses an organometallic catalyst to transiently co-locate para-H₂ and the target substrate molecule in a low-symmetry complex in solution. In low field (e.g., 5-7 mT), net spin order can be transferred from the para-H₂ to the spins of the substrate via scalar couplings. However, achieving efficient hyperpolarization via SABRE has been limited to protons, which depolarize quickly (T₁ of seconds), precluding metabolic tracking on biologically relevant timescales. It also presents background issues from water. Heteronuclei such as ¹⁵N are much more attractive for hyperpolarization because they often have long polarization lifetimes or singlet population relaxation times (T_(S)) in special cases exceeding ten minutes. SABRE derived proton hyperpolarization can be transferred to heteronuclei, but the associated efficiency is low, producing only ˜0.03% polarization. Accordingly, there exists a need for methods of hyperpolarization of heteronuclei.

SUMMARY

In one aspect, disclosed is a method of hyperpolarizing heteronuclei, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; and (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus.

Other aspects of the present disclosure include methods of performing NMR experiments, methods of obtaining MRI images, and other methods of in vivo imaging.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A, FIG. 1B, and FIG. 1C is a diagram of the experimental setup for SABRE-SHEATH using a 5 mm NMR tube and the magnetic shield; para-H₂ gas is supplied from a pressurized tank, regulated (via a flow meter), and bubbled through 1/16 in. tubing placed inside the 5 mm NMR tube under 1-7 atm para-H₂ pressure. “Used” para-H₂ gas leaves the NMR sample via an exhaust line. FIG. 1B is a diagram of in situ SABRE (9.4 T) and low-field (ex situ) SABRE performed using a 9.4 T NMR magnet and within its fringe field, respectively. All NMR detection was performed at 9.4 T. FIG. 1C shows the sequence of events for SABRE-SHEATH hyperpolarization.

FIG. 2A is a generalized representation of AA′BB′ showing relevant spin-spin couplings. FIG. 2B shows a AA′BB′ spin system formed by two Ir-hydride protons and two ¹⁵N sites of two exchangeable ¹⁵N-pyridines shown in the structural diagram of the activated Ir-IMes catalyst using ¹⁵N-Py substrate.

FIG. 3A illustrates an initial state in the z-direction (population on the diagonal element) rotating about a Hamiltonian along x. This Hamiltonian has real positive off-diagonal and zero diagonal elements. FIGS. 3B and 3C illustrate the SABRE-SHEATH hyperpolarization process. FIG. 3B shows hyperpolarization transfer dictated by eq 5a. Here, the off-diagonal elements, −ΔJ_(AB)/2, are real and negative (isomorphic with −σ_(x)); hence, this part of the Hamiltonian is depicted along −x. The initial population of |S^(A)S^(B)

on the diagonal is represented by a vector along +z. This is then rotated by the J-coupling term into a vector along −z representing population of the targeted state |T⁻T₊

. FIG. 3C shows hyperpolarization transfer dictated by eq 5b according to the same principles: Initial |S₀T⁻

population on the diagonal along +z is rotated into a population of |T⁻S₀

along −z by a Hamiltonian with real and positive off-diagonal elements, ΔJ_(AB)/2, represented along +x. In the diagrams, initial and final states are represented by the most faded and most solid vectors, respectively.

FIGS. 4A, 4B, 4C, and 4D depict single-shot ¹⁵N-NMR spectra from ¹⁵N-pyridine (¹⁵N-Py) SABRE experiments. FIG. 4A shows a SABRE-SHEATH experiment with Ir-catalyst/¹⁵N-Py concentrations of 0.24 mM and 4 mM respectively. Detected 30,000-fold signal enhancement corresponds to ˜10% polarization. FIG. 4B shows that increase of Ir-catalyst/¹⁵N-Py concentrations results in the absolute NMR signal amplification, but relative enhancement and polarization levels decrease. An in-phase triplet split by 11 Hz is found, in both, 4A and 4B. FIG. 4C shows that when attempting ¹⁵N SABRE at the conditions optimized for proton hyperpolarization (6±4 mT) an anti-phase triplet with lower enhancement is observed.

FIGS. 5A, 5B, 5C AND 5D show ¹H-NMR spectra obtained via SABRE from ¹⁴N-Py vs. ¹⁵N-Py experiments. SABRE polarization was conducted in both the ˜6±4 mT field (FIGS. 5A and 5B) and in the shield (FIGS. 5C and 5D) for ¹⁴N-Py vs. ¹⁵N-Py at 63 mM Py and 6.3 mM catalyst concentrations. ¹H-SABRE enhancement levels are shown for the ortho-proton of Py (˜8.5 ppm) of each spectrum. Additionally, the hydride region (˜−22.8 ppm) is shown, highlighting the significant difference in line shape between ¹⁵N-Py and ¹⁴N-Py: a sharp singlet of ¹⁴N-Py vs. anti-phase resonance of ¹⁵N-Py.

FIG. 6A shows a ¹H thermal NMR spectrum of 2 mM activated Ir-IMes catalyst solution with 48 mM ¹⁵N-pyridine. FIG. 6B shows a ¹H NMR spectrum of hyperpolarized ¹⁵N-Py via conventional low-field (6±4 mT) SABRE. The resonances labeled with dashed lines correspond to catalyst-associated Py. FIG. 6C-F show ¹⁵N NMR spectra of ¹⁵N-Py hyperpolarized by SABRE-SHEATH. FIG. 6C shows an NMR spectrum of ¹⁵N-Py (ε_(free)˜300) sample corresponding to completely activated catalyst solution (as validated by ¹H NMR using conventional low-field SABRE through achieving efficient enhancement of Py proton polarization, and also validated through in situ detection of the disappearance of SABRE hyperpolarized Ir-hydride intermediate species). FIG. 6D shows an ¹⁵N NMR spectrum of a ¹⁵N-Py sample corresponding to maximum SABRE-SHEATH signal intensity (ε_(free)˜3600) achieved with ˜20 min of para-H₂ bubbling (with a ˜20% duty cycle, para-H₂ bubbling at this step was used for sample-degassing purposes; actual para-H₂ bubbling for SABRE-SHEATH was only ˜30 s) after acquisition of the spectrum shown in FIG. 6C (but with the same para-H₂ bubbling time of ˜30 s for SABRE-SHEATH hyperpolarization). FIG. 6E shows an ¹⁵N NMR spectrum (ε_(free)≈185) of ¹⁵N-Py sample after it was exposed to air; the spectrum is recorded ˜23 min after spectrum shown in FIG. 6C. FIG. 6F shows an ¹⁵N NMR spectrum of ¹⁵N-Py sample after SABRE-SHEATH intensities (ε_(free)≈3600) fully recovered from exposure to air; the spectrum was recorded ˜31 min after the spectrum shown in FIG. 6C.

FIG. 7A shows a schematic of SABRE showing ¹⁵N-Py and para-H₂ exchange on the activated Ir-IMes catalyst producing efficient ¹⁵N hyperpolarization. FIG. 7B is an ¹⁵N NMR spectrum of HP 4 mM ¹⁵N-Py (0.24 mM catalyst) via SABRE-SHEATH procedure using ˜6 atm of para-H₂ pressure. FIG. 7C shows the corresponding ¹⁵N reference signal from neat ¹⁵N-Py. FIG. 7D is a graph depicting ¹⁵N SABRE-SHEATH signal dependence on the para-H₂ flow rate (sccm) at various para-H₂ pressures: 1.0, 2.7, 5.1, and 7.1 atm. The data acquired in FIG. 7D utilized [catalyst]/[¹⁵N-Py]=4 mM/96 mM. FIG. 7E is a graph depicting ¹⁵N SABRE-SHEATH signal dependence on temperature at ˜6 atm para-H₂ pressure. The data acquired in FIG. 7E utilized [catalyst]/[¹⁵N-Py]=2 mM/48 mM. FIG. 7F is a series of graphs depicting ¹⁵N T₁ measurements at three different magnetic field strengths: T regime ([catalyst]/[¹⁵N-Py]=0.2 mM/20 mM) in the magnetic shield, ˜6 mT fringe field ([catalyst]/[¹⁵N-Py]=6 mM/63 mM), and 9.4 T ([catalyst]/[¹⁵N-Py]=0.2 mM/20 mM) field inside the NMR spectrometer.

FIGS. 8A, 8B, 8C, 8D, 8E and 8F depict a summary of ¹⁵N relaxation times T₁ at the microtesla (μT) field inside the magnetic shield (T₁ ^(μT)) and at 9.4 T (T₁ ^(9T)) and percentage ¹⁵N polarization (% P) for ¹⁵N SABRE-SHEATH of ¹⁵N-Py for various Ir-IMes catalyst and ¹⁵N-Py concentrations. FIGS. 8A and 8E depict a dilution series corresponding to ˜1:16 catalyst to ¹⁵N-Py ratio. FIGS. 8B and 8F depict a series of catalyst/¹⁵N-Py solutions with fixed catalyst concentration. FIGS. 8C and 8D depict a series of catalyst/¹⁵N-Py solutions with fixed ¹⁵N-Py concentrations at 100 mM and 20 mM.

FIGS. 9A, 9B, 9C, 9D, 9E and 9F depict a series of NMR spectra comparing ¹³C and ¹⁵N SABRE signal enhancements. FIG. 9A depicts ¹⁵N SABRE using SABRE-SHEATH at T field. FIG. 9B depicts ¹⁵N SABRE using SABRE-SHEATH at ˜6 mT for a 63 mM ¹⁵N-Py sample with 6 mM of Ir-IMes catalyst. FIG. 9C shows a thermally polarized reference spectrum of 12.5 M ¹⁵N-Py used as the polarization enhancement reference for ¹⁵N SABRE. The intensity scale for the spectrum corresponding to the conventional (low-field) SABRE at ˜6 mT (shown in 9B) is zoomed in to twice the level of the T SABRE ¹⁵N spectrum (shown in 9A), while the ¹⁵N-Py reference spectrum (shown in 9C) is zoomed in 12-fold. FIG. 9D shows ¹³C SABRE conducted on the same sample at T field and FIG. 9E shows ¹³C SABRE at ˜6 mT. FIG. 9F shows the ¹³C polarization/signal reference in neat methanol (24 M at ˜1.1% natural abundance of ¹³C. All of the ¹³C SABRE spectra are plotted on the same intensity scale. The polarization enhancements (E) for selected peaks are shown for their respective spectra.

FIG. 10A depicts an ¹⁵N single-scan NMR spectrum of a thermal reference sample of ¹⁵NH₄Cl in an aqueous medium and HP ¹⁵N-Py at 20.3 MHz using the following acquisition parameters: RF pulse width (pw)=128 μs (90°), spectra width (sw)=19 840 Hz, acquisition time (acq)=0.5 s. FIG. 10B shows a ¹⁵N 2D projection gradient echo (GRE) MRI using the following acquisition parameters: slice thickness=60 mm, pulse width=500 μs (˜15°), field of view=64×64 mm2, imaging matrix size=32×32 pixels, pixel size (spatial resolution)=2×2 mm², repetition time (TR)=13 ms, echo time (TE)=6.4 ms, acq=10.6 ms, sw=3005 Hz, and total scan time ˜0.4 s. The image was post-processed with zero filling to 256×256 points for enhanced presentation.

FIGS. 11A, 11B, 11C, 11D, 11E and 11F illustrate the SABRE of “neat” natural abundance ¹⁵N (0.36%) pyridine (Py). FIG. 11A depicts a ¹⁵N SABRE-SHEATH hyperpolarized spectrum and the corresponding thermally polarized reference spectrum after 192 signal averages. FIG. 11B depicts a ¹H SABRE spectrum of a hyperpolarized sample in a milliTesla magnetic field (˜6 mT) and the corresponding NMR spectrum using a thermally polarized sample. FIG. 11C depicts the effect of the para-H₂ flow rate (measured in standard cubic centimeters per minute or sccm) on ¹⁵N signal enhancement at ˜90 mM catalyst concentration under five para-H₂ pressure values. FIG. 11D depicts the effect of [Py] to [catalyst]ratio on ¹⁵N signal enhancement using 120 sccm flow rate under ˜7 atm of para-H₂ pressure. FIG. 11E depicts the ¹⁵N SABRE-SHEATH dependence (modeled as exponential decay) as a function of the sample exposure to the microTesla magnetic field after stopping para-H₂ bubbling time. FIG. 11F depicts the ¹⁵N T₁ decay at 9.4 T. The experiments in panels E and F are conducted using ˜90 mM catalyst concentration (˜140:1 [Py] to [catalyst]ratio) at 120 sccm flow rate and ˜7 atm para-H₂ pressure.

FIGS. 12A and 12B illustrate diagrams of para-H₂ exchange and ¹⁵N SABRE-SHEATH hyperpolarization in the absence (FIG. 12A) and in the presence (FIG. 12B) of ¹⁴N-Py excess. The exchange with ¹⁴N-Py does not cause a significant reduction in the spin order of the para-H₂ pool. Both equatorial pyridines of the active complex undergo the chemical exchange with free Py in solution, while the axial pyridine (labeled as “Py”) is not exchangeable.

FIGS. 13A and 13B illustrate spin systems used for analytical derivation of the resonance conditions for (FIG. 13A) ¹⁵N-Py solutions and (FIG. 13B) n.a. Py solutions. In panel A, in addition to the displayed couplings, J_(HN)=J_(H′N′) and J_(HN′)=J_(H′N). Couplings to spins in axial positions are ignored because they generally are smaller than equatorial couplings and play a subordinate role. (Additionally, this site does not exchange with free substrate.)

FIG. 14 shows the chemical structures and maximum ¹⁵N SABRE-SHEATH signal enhancements obtained for pyridine, picolines, and lutidines in neat liquids using ˜45 mM catalyst concentration and naturally abundant levels of ¹⁵N (˜0.35%) under ˜7 atm of para-H₂ pressure and flow rate of 100-120 sccm. The value labeled with a single asterisk (*) corresponds to the optimized catalyst concentration of ˜90 mM, the values labeled with double asterisks (**) correspond to the experiments conducted at 5 atm of para-H₂ and the flow rate of 60 sccm, and n.d. stands for none detected.

FIG. 15 demonstrates the SABRE-SHEATH hyperpolarization of imidazole and the change in ¹⁵N chemical shift with protonation of the imidazole nitrogen.

FIG. 16A is a chemical structure depicting the most probable Ir-catalyst complex and the exchange of para-H₂ and Py substrate when catalyst is activated with n.a. Py in a SABRE-SHEATH experiment. FIG. 16C shows the decay and fitting model of ¹⁵N signal detected at 9.4 T as a function of sample exposure time to microTesla magnetic field of the shield after stopping para-H₂ flow. FIG. 16B shows ¹⁵N T₁ decay of hyperpolarized signal measured at 9.4 T using small degree (˜7°) excitation RF pulse.

FIG. 17A is a chemical structure depicting the most probable Ir-catalyst complex (from the perspective relevant to ¹⁵N SABRE-SHEATH hyperpolarization process) and the exchange of para-H₂ and Py-d substrate. The catalyst is activated with natural Py-d₅ (99.5% deuterium enrichment) and natural abundance level of ¹⁵N. FIG. 17B shows ¹⁵N T₁ decay of hyperpolarized signal measured at 9.4 T using small degree (˜7°) excitation RF pulse. FIG. 17C shows the decay and fitting model of ¹⁵N signal detected at 9.4 T as a function of sample exposure time to microTesla magnetic field of the shield after stopping para-H₂ flow.

FIG. 18A is a chemical structure depicting the most probable Ir-catalyst complex (from the perspective relevant to ¹⁵N SABRE-SHEATH hyperpolarization process) and the exchange of para-H₂ and ¹⁵N enriched (99% ¹⁵N) ¹⁵N-Py substrate. The catalyst is activated with ¹⁵N-Py. FIG. 18B shows the ¹⁵N T₁ decay of hyperpolarized signal measured at 9.4 T using small degree (˜7°) excitation RF pulse. FIG. 18C shows the decay and fitting model of ¹⁵N signal detected at 9.4 T as a function of sample exposure time to microTesla magnetic field of the shield after stopping para-H₂ flow.

FIG. 19A is a chemical structure depicting the most probable Ir-catalyst complex (from the perspective relevant to ¹⁵N SABRE-SHEATH hyperpolarization process) and the exchange of para-H₂ and ¹⁵N-Py/Py-d₅ substrates. The catalyst is activated with ¹⁵N-Py, which is reflected in the occupant of nonexchangeable (axial) ligand position. FIG. 19B shows the ¹⁵N T₁ decay of hyperpolarized signal measured at 9.4 T using small degree (˜7°) excitation RF pulse. FIG. 19C shows the decay and fitting model of ¹⁵N signal detected at 9.4 T as a function of sample exposure time to microTesla magnetic field of the shield after stopping para-H₂ flow.

FIG. 20A is a chemical structure depicting the most probable Ir-catalyst complex (from the perspective relevant to ¹⁵N SABRE-SHEATH hyperpolarization process) and the exchange of para-H₂ and ¹⁵N-Py/Py-d₅ substrates. FIG. 20B shows the ¹⁵N T₁ decay of hyperpolarized signal measured at 9.4 T using small degree (˜7°) excitation RF pulse. FIG. 20C shows the decay and fitting model of ¹⁵N signal detected at 9.4 T as a function of sample exposure time to microTesla magnetic field of the shield after stopping para-H₂ flow.

FIG. 21A is a chemical structure depicting the most probable Ir-catalyst complex (from the perspective relevant to ¹⁵N SABRE-SHEATH hyperpolarization process) and the exchange of para-H₂ and ¹⁵N-Py/n.a. Py substrates. FIG. 21B shows the ¹⁵N T₁ decay of hyperpolarized signal measured at 9.4 T using small degree (˜7°) excitation RF pulse. FIG. 21C shows the decay and fitting model of ¹⁵N signal detected at 9.4 T as a function of sample exposure time to microTesla magnetic field of the shield after stopping para-H₂ flow.

FIG. 22A is a chemical structure depicting the most probable Ir-catalyst complex (from the perspective relevant to ¹⁵N SABRE-SHEATH hyperpolarization process) and the exchange of para-H₂ and ¹⁵N-Py/n.a. Py substrates. The catalyst is activated with n.a. Py, which is reflected in the occupant of nonexchangeable (axial) ligand position. FIG. 22B shows the ¹⁵N T₁ decay of hyperpolarized signal measured at 9.4 T using small degree (˜7°) excitation RF pulse. FIG. 22C shows the decay and fitting model of ¹⁵N signal detected at 9.4 T as a function of sample exposure time to microTesla magnetic field of the shield after stopping para-H₂ flow.

DETAILED DESCRIPTION

Disclosed herein is a method of directly transferring para-H₂ polarization to heteronuclei, using extremely low magnetic fields (on the order of a microTesla), without the need of rf irradiation or pulses. This hyperpolarization strategy may be referred to as SABRE-SHEATH (SABRE in SHield Enables Alignment Transfer to Heteronuclei). The methods include using transition metal catalysts for nuclear spin polarization enhancement in neat liquids via SABRE-SHEATH.

The methods offer significant advantages over existing methods of hyperpolarization of heteronuclei, including the ability to perform the experiments on a shorter timescale with greater polarization and signal enhancement. For example, the disclosed methods demonstrate up to 10% polarization directly on ¹⁵N, corresponding to signal gains of 30,000 fold at 9.4 T.

The advantages of the disclosed method promote the broad applicability of SABRE-SHEATH in biophysical and biomedical imaging experiments, allowing this technique to be useful, for example, in minimally invasive biomedical applications.

1. DEFINITIONS

Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. In case of conflict, the present document, including definitions, will control. Preferred methods and materials are described below, although methods and materials similar or equivalent to those described herein can be used in practice or testing of the present invention. All publications, patent applications, patents and other references mentioned herein are incorporated by reference in their entirety. The materials, methods, and examples disclosed herein are illustrative only and not intended to be limiting.

The terms “comprise(s),” “include(s),” “having,” “has,” “can,” “contain(s),” and variants thereof, as used herein, are intended to be open-ended transitional phrases, terms, or words that do not preclude the possibility of additional acts or structures. The singular forms “a,” “an” and “the” include plural references unless the context clearly dictates otherwise. The present disclosure also contemplates other embodiments “comprising,” “consisting of” and “consisting essentially of,” the embodiments or elements presented herein, whether explicitly set forth or not.

The conjunctive term “or” includes any and all combinations of one or more listed elements associated by the conjunctive term. For example, the phrase “an apparatus comprising A or B” may refer to an apparatus including A where B is not present, an apparatus including B where A is not present, or an apparatus where both A and B are present. The phrases “at least one of A, B, . . . and N” or “at least one of A, B, . . . N, or combinations thereof” are defined in the broadest sense to mean one or more elements selected from the group comprising A, B, . . . and N, that is to say, any combination of one or more of the elements A, B, . . . or N including any one element alone or in combination with one or more of the other elements which may also include, in combination, additional elements not listed.

Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. For example, if a concentration range is stated as 1% to 50%, it is intended that values such as 2% to 40%, 10% to 30%, or 1% to 3%, etc., are expressly enumerated in this specification. These are only examples of what is specifically intended, and all possible combinations of numerical values between and including the lowest value and the highest value enumerated are to be considered to be expressly stated in this application.

The modifier “about” used in connection with a quantity is inclusive of the stated value and has the meaning dictated by the context (for example, it includes at least the degree of error associated with the measurement of the particular quantity). The modifier “about” should also be considered as disclosing the range defined by the absolute values of the two endpoints. For example, the expression “from about 2 to about 4” also discloses the range “from 2 to 4.” The term “about” may refer to plus or minus 10% of the indicated number. For example, “about 10%” may indicate a range of 9% to 11%, and “about 1” may mean from 0.9-1.1. Other meanings of “about” may be apparent from the context, such as rounding off, so, for example “about 1” may also mean from 0.5 to 1.4.

The term “heterogeneous catalyst,” as used herein, means a catalyst that is in a separate phase from the reactants. For example, the heterogeneous catalyst used in the methods described herein may be a heterogeneous catalyst in U.S. patent application Ser. No. 14/801,541, the contents of which are incorporated herein in their entirety. The heterogeneous transition metal catalyst described herein may also be in U.S. patent application Ser. No. 14/801,541.

The term “homogeneous catalyst,” as used herein, means a catalyst that is in the same phase as the reactants. For example, the homogeneous catalyst used in the methods described herein may be a homogeneous catalyst in U.S. patent application Ser. No. 14/801,554, the contents of which are incorporated herein in their entirety. The homogeneous transition metal catalyst described herein may also be in U.S. patent application Ser. No. 14/801,554.

The term “isotopically enriched,” as used herein with reference to any particular isotope of any particular atom of a compound, means that in a composition comprising a plurality of molecules of the compound, the amount (e.g., fraction, ration or percentage) of the plurality of molecules having the particular isotope at the particular atom is substantially greater than the natural abundance of the particular isotope, due to synthetic enrichment of the particular atom with the particular isotope. For example, a composition comprising a compound with an isotopically enriched ¹⁵N atom at a particular location includes a plurality of molecules of the compound where, as a result of synthetic enrichment, the percentage of the plurality of molecules having ¹⁵N at that location is greater than about 1% (the natural abundance of ¹⁵N is substantially less than 1%), and in many cases is substantially greater than about 1%. Similarly, a composition comprising a compound with an isotopically enriched deuterium (D) atom at one or more particular locations includes a plurality of molecules of the compound, where as a result of synthetic enrichment, the percentage of the plurality of molecules having D at each of the one or more particular locations is greater than about 1% (the natural abundance of D is substantially less than 1%), and in many cases is substantially greater than about 1%. In some cases, a composition comprising a compound with an isotopically enriched atom at a particular location may include a plurality of molecules of the compound, where the amount of the plurality of molecules having the isotope at the location may be at least about two-or-more-fold greater than the natural abundance of the isotope, including but not limited to at least about two-fold, at least about three-fold, at least about four-fold, at least about five-fold, at least about 10-fold, at least about 20-fold, at least about 30-fold, at least about 40-fold, at least about 50-fold, at least about 60-fold, at least about 70-fold, at least about 80-fold, at least about 90-fold, at least about 100-fold, and at least about 200-fold, among others. In some cases, a composition comprising a compound with an isotopically enriched atom at a particular location also may include a plurality of molecules of the compound where, as a result of synthetic enrichment, at least about 1%, at least about 5%, at least about 10%, at least about 15%, at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50%, at least about 55%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, or at least about 95%, of the plurality of molecules have the isotope at the location.

The term “natural abundance,” as used herein with reference to any particular isotope of an element, refers to the abundance of the isotope as naturally found on the planet Earth. For example, the natural abundance of ¹⁵N on the planet Earth is generally regarded to be about 0.37% (i.e., substantially less than about 1%), while the natural abundance of deuterium (D) on the planet Earth is generally regarded to be about 0.015% (i.e., substantially less than about 1%).

2. SABRE-SHEATH

In one aspect, described herein is a method of directly transferring para-H₂ polarization to heteronuclei, using extremely low magnetic fields (microTesla), without the need of rf irradiation or pulses. The heteronuclei may comprise ¹⁵N, ¹³C, ²⁹Si, ³¹P or ¹⁹F.

To promote efficient hyperpolarization transfer, frequency differences between the para-H₂-derived hydride protons and the to-be-polarized target nuclei should preferably match the J-coupling interactions that connect the polarization source and target nuclei.

In certain embodiments, efficient transfer of hyperpolarization from nascent parahydrogen protons of Ir-hydride to heteronuclei (e.g., ¹⁵N-Py) in a SABRE experiment is possible if the frequency difference between the Ir-hydride protons and ¹⁵N on the complex matches specific J-coupling terms, as displayed in FIG. 2. As derived below, both of the following resonance conditions enable hyperpolarization transfer:

Δv _(HN) =|J _(HH) +J _(NN)−(J _(HN) +J _(HN′))/2|  (1)

Δv _(HN) =|J _(HH) −J _(NN)|  (2)

where Δv_(HN)=v_(H)−v_(N) is the frequency difference between Ir-hydride protons and catalyst-bound ¹⁵N, and the J-couplings are as depicted in FIG. 2.

The two hydride protons and two ¹⁵N nuclei within the two exchangeable substrates form an AA′BB′ spin system. Within this AA′BB′ system, the polarization transfer takes place. In general, the Hamiltonian of an AA′BB′ system is given as

H=v _(A)(I _(Az) +I′ _(Az))+v _(B)(I _(Bz) +I′ _(Bz))+J _(AA) ·I _(A) I′ _(A) +J _(BB) ·I _(B) I′ _(B) +J _(AB)·(I _(A) I _(B) +I′ _(A) I′ _(B))+J′ _(AB)·(I′ _(A) I _(B) +I _(A) I′ _(B))  (3)

To gain intuition about the polarization transfer dynamics, it is useful to embrace the vector representation of spin rotations. For example, in the traditional (one spin-½) vector representation, the position along +z corresponds to the spin state |α

and the position along −z corresponds to spin state |β

. Thus, an initial spin state |α

could be rotated by a Hamiltonian pointing along x as depicted in FIG. 3A. This matrix element connects |α

and |β

, transferring population in |α

to population in |β

. The corresponding density matrix representation of initial state, pi with population in |α

, x-Hamiltonian, ′H_(x), and final state, ρ_(f) with population in |β

, are

$\begin{matrix} {\begin{matrix} {{\langle\alpha }{\langle\beta }} \\ {\rho_{i} = {\begin{matrix} {\alpha\rangle} \\ {\beta\rangle} \end{matrix}\begin{pmatrix} 1 & 0 \\ 0 & 0 \end{pmatrix}}} \end{matrix},\begin{matrix} {{\langle\alpha }{\langle\beta }} \\ {\mathcal{H}_{x} = {\begin{matrix} {\alpha\rangle} \\ {\beta\rangle} \end{matrix}\begin{pmatrix} 0 & 1 \\ 1 & 0 \end{pmatrix}}} \end{matrix},{{and}\mspace{14mu} \begin{matrix} {{\langle\alpha }{\langle\beta }} \\ {\rho_{f} = {\begin{matrix} {\alpha\rangle} \\ {\beta\rangle} \end{matrix}\begin{pmatrix} 0 & 0 \\ 0 & 1 \end{pmatrix}}} \end{matrix}}} & (4) \end{matrix}$

where useful features include that populations are represented by real on-diagonal elements and the x-Hamiltonian is represented by real off-diagonal elements without contributions on the diagonal.

The hyperpolarization transfer process in AA′BB′ systems may be understood by choosing the right basis set and using the following equations with the singlet-triplet basis applied to both the A spin pair and the B spin pair:

$\begin{matrix} {{T_{+} = {{\alpha\alpha}\rangle}},\mspace{14mu} {T_{-} = {{\beta\beta}\rangle}},\mspace{14mu} {T_{0} = {\frac{1}{\sqrt{2}}\left( {{{\alpha\beta}\rangle} + {{\beta\alpha}\rangle}} \right)}},{{{and}\mspace{14mu} S_{0}} = {\frac{1}{\sqrt{2}}\left( {{{\alpha\beta}\rangle} - {{\beta\alpha}\rangle}} \right)}}} & (5) \end{matrix}$

Combining the A states and the B states results in 4×4=16 total states (for example, the “singlet A-singlet B” state |S^(A) S^(B)

). Para-H₂ is the prototypical singlet state and populates all four states that contain S^(A). SABRE-SHEATH experiments may work with |S₀S₀

and |S₀T⁻

, which are coupled, by the AA′BB′ Hamiltonian, to |T⁻T₊

and |T⁻S₀

, respectively:

$\begin{matrix} {\mathcal{H}_{{AA}^{\prime}{BB}^{\prime}} = \begin{matrix} {\langle{S_{0}^{A}S_{0}^{B}}} & {\langle{T_{-}^{A}T_{+}^{B}}} \\ \begin{matrix} {{S_{0}^{A}S_{0}^{B}}\rangle} \\ {{T_{-}^{A}T_{+}^{B}}\rangle} \end{matrix} & \begin{pmatrix} {- \left( {J_{AA} + J_{BB}} \right)} & {{- \Delta}\; {J_{AB}/2}} \\ {{- \Delta}\; {J_{AB}/2}} & {\frac{\Sigma \; J_{AB}}{2} - \left( {v_{A} - v_{B}} \right)} \end{pmatrix} \end{matrix}} & \left( {5a} \right) \\ {{\mathcal{H}_{{AA}^{\prime}{BB}^{\prime}} = \begin{matrix} {\langle{S_{0}^{A}S_{0}^{B}}} & {\langle{T_{-}^{A}T_{+}^{B}}} \\ \begin{matrix} {{S_{0}^{A}S_{0}^{B}}\rangle} \\ {{T_{-}^{A}T_{+}^{B}}\rangle} \end{matrix} & \begin{pmatrix} {- \left( {J_{AA} + J_{BB}} \right)} & {{- \Delta}\; {J_{AB}/2}} \\ {{- \Delta}\; {J_{AB}/2}} & {{- \left( {v_{A} - v_{B}} \right)} - \frac{\Sigma \; J_{AB}}{2}} \end{pmatrix} \end{matrix}}{{{where}\mspace{14mu} \Delta \; J_{AB}} = {{J_{AB} - {J_{{AB}^{\prime}}\mspace{14mu} {and}\mspace{14mu} \Sigma \; J_{AB}}} = {J_{AB} + {J_{{AB}^{\prime}}.}}}}} & \left( {5b} \right) \end{matrix}$

The form of eq 5a implies that population can be transferred from |S₀S₀

to |T₊T⁻

when the difference between the diagonal elements in that part of the Hamiltonian becomes small. For example, when the diagonal elements are equalized as −(J_(AA)+J_(BB))=ΣJ_(AB)/2−(v_(A)−v_(B)), then the off-diagonal elements can take full effect and rotate population from |S₀S₀

to |T⁻T₊

, as depicted in FIG. 3B: The off diagonal elements −ΔJ_(AB)/2 are real and negative (isomorphic with −σ_(x)); hence, they are depicted as a vector along −x. This process forms hyperpolarization in the T₊ state of the targeted (B) spins corresponding to detectable magnetization. Hence, from eq 5a the first resonance condition given in eq 1 can be deduced (by equalizing the diagonal elements). Similarly, eq 5b shows that hyperpolarization can be transferred from the |S₀T⁻

diagonal element to |T⁻S₀

when the diagonal elements in the Hamiltonian are equalized −v_(B)−J_(AA)=−v_(A)−J_(BB), as illustrated in FIG. 3C, establishing the second resonance condition given in eq 2. Hyperpolarization can be observed because T^(B) is depleted, in effect creating overpopulation in T₊, just as predicted by the first resonance condition as well. Over-population in T^(B) ₊ corresponds to alignment with the main magnetic field only for species with positive γ (e.g., ¹³C); for species with negative γ (such as ¹⁵N), overpopulation in T₊ corresponds to anti-alignment with the main magnetic field—in accordance with the experimental observations detailed below. In the scenario that J_(HH) (˜9 Hz) dominates the J-coupling terms, all resonance conditions (those of eqs 1 and 2) are satisfied simultaneously, and a useful hyperpolarization transfer field can be estimated as B_(0-transfer)≈J_(HH)/(γ_(A)−γ_(B))≈0.26 μT, assuming a J-coupling term (J_(HH)) of ˜9 Hz (FIG. 2).

The resonance conditions need not be met precisely, because continuous exchange of para-H₂ and substrate reduce the residence times typically to about 0.2 s. For short times (relative to any resonance condition mismatch), the mismatch has only a modest effect on the population transfer. This implies that the effect of multiple exchanges will tend to equilibrate the populations of the states |S₀S₀

and |T⁻T₊

, and of the states |S₀T⁻

and |T⁻S₀

. This assertion is also backed by the experimental observation that the specified resonance matching conditions do not have to be met exactly; instead, if the magnetic field has the adequate order of magnitude, then the desired effect is observed. In this sense, the magnetic field simply has to be low enough, however “true” zero field would likely not produce the observed effects because a sufficient difference between T₊ and T⁻ states must prevail in order to create alignment along the residual magnetic field.

In certain embodiments, the magnetic field causes the matching of the resonance frequency of parahydrogen with the resonance frequency of at least one hyperpolarizable heteronucleus in a compound. In certain embodiments, the resonance frequencies of parahydrogen and the hyperpolarizable heteronuclei are different. In certain embodiments, the resonance frequencies of parahydrogen and the hyperpolarizable heteronuclei are within an order of magnitude of each other.

In certain embodiments, the magnetic field is less than the Earth's magnetic field. In certain embodiments, the magnetic field is less than 50 μT, less than 45 μT, less than 40 μT, less than 35 μT, less than 30 μT, less than 25 μT, less than 20 μT, less than 15 μT, less than 10 μT, less than 5 μT, less than 4 μT, less than 3 μT, less than 2 μT, or less than 1 μT. In certain embodiments, the magnetic field is about 0.1 to about 50 μT, about 0.1 to about 45 μT, about 0.1 to about 40 μT, about 0.1 to about 35 μT, about 0.1 to about 30 μT, about 0.1 to about 25 μT, about 0.1 to about 20 μT, about 0.1 to about 15 μT, about 0.1 to about 10 μT, about 0.1 to about 5 μT, about 0.1 to about 4 μT, about 0.1 to about 3 μT, about 0.1 to about 2 μT, about 0.1 to about 1 μT, about 0.1 to about 0.5 μT, about 0.1 to about 0.4 μT, about 0.1 to about 0.3 μT, about 0.2 to about 0.4 μT, or about 0.2 to about 0.3 μT.

3. SABRE-SHEATH METHOD

The disclosed method may include bubbling para-H₂ through a solution containing activated catalyst and ¹⁵N-Py inside a gi-metal magnetic shield where the hyperpolarization is created (FIG. 1). Subsequently, the sample may be transferred into an NMR magnet for detection by a simple 90° pulse resulting in in-phase signal. This in-phase signal may be useful in imaging applications, where the associated broader lines would suffer signal cancellations if the signals were anti-phase.

SABRE-SHEATH polarization can be demonstrated by placing the NMR tube in a 305 mm-long magnetic shield (Lake Shore Cryotronics, P/N 4065) with ˜30 s of bubbling of para-H₂. After this ˜30 s polarization period, para-H₂ delivery can be stopped, and the NMR tube quickly transferred (˜4 s) to a 9.4 T Bruker Avance III NMR spectrometer to detect the SABRE-SHEATH polarization through conventional 1D-NMR. Both ¹⁵N and ¹H pulse-acquire NMR experiments can be conducted.

FIG. 4 shows results of SABRE-SHEATH experiments. At concentrations of 4 mM ¹⁵N-Py (and 0.24 mM catalyst), a 30,000-fold polarization enhancement over the thermal level is achieved (FIG. 4A). The thermal ¹⁵N polarization at 9.4 T and room temperature is ˜3.3×10⁶, thus this enhancement corresponds to a ¹⁵N polarization of ˜10%. This polarization is not adjusted for relaxation that may occur during sample transfer from magnetic shield to detection region, and the polarization created in the shield may be larger.

Spectra obtained with the 63 mM ¹⁵N-pyridine (6.3 mM catalyst, FIG. 4B) illustrates that with increasing concentrations, the absolute signal can be further increased but the corresponding enhancement level (and the respective polarization, P) is diminished to 3,000 fold (P˜1%). The reduced enhancements observed with increasing concentrations may be limited by three factors: (i) the finite amount of dissolved para-H₂ may limit the available hyperpolarization that can be passed to ¹⁵N-Py molecules; (ii) the Ir-catalyst and Py concentrations modulate Py residency time, which may affect the efficiency of SABRE polarization transfer; (iii) NHC Ir-catalyst may be a source of T₁ relaxation, which in turn may limit the maximum polarization level.

The spectral pattern observed for the free Py in the SABRE-SHEATH experiments (FIGS. 4A and 4B) is as clean in-phase triplet because the dominant two-bond J-coupling between ¹⁵N and the ortho-Py-protons ²J_(NH) is ≈11 Hz. In the traditional low-field SABRE experiment (at ˜6 mT) for protons the ¹⁵N-triplet is associated with lower enhancements, but also, it is purely anti-phase, which makes this signal much less useful in imaging applications, because of partial signal cancellation that occurs when spectral lines are broadened.

In the SABRE-SHEATH experiments, (FIGS. 4A and 4B), the free Py and the ligand bound species are both detected. The equatorial Py molecules in the catalytic intermediate exchange quickly and produce the observed hyperpolarization on the free Py. The axial pyridine does not exchange or significantly participate in the hyperpolarization dynamics, but it is visible in the SABRE-SHEATH experiments. This axial pyridine is no longer detectable in the experiments optimized for ¹H SABRE (FIG. 4C), where antiphase lines result. The NMR lines of the catalyst bound species are intrinsically broadened. Thus, the in-phase lines are still easily observable in SABRE-SHEATH experiments (FIGS. 4A and 4B), however the experiments conducted at ˜6±4 mT (FIG. 4C) exhibit anti-phase lines and suffer from signal cancellation in addition to already lower enhancements.

The theory described herein predicts the in-phase signals resulting from standard I_(z)-magnetization in the SABRE-SHEATH experiments. It is speculated that the antiphase signals in the 6±4 mT experiments arise because the initial singlet spin-order of para-H₂ is transferred, not only into I_(z)-magnetization on protons, but also into zero-quantum terms (e.g., ZQ_(x)=I_(1x)I_(2x)+I_(1y)I_(2y)) on pairs of Py protons, which are finally transferred (by the ²J_(NH)-coupling ∝ I_(z)S_(z)) into anti-phase terms between protons and ¹⁵N (e.g. I_(1z)I_(2z)S_(y)) resulting in anti-phase signals. An additional indication for the involvement of anti-phase and zero-quantum terms are the anti-phase NMR signals also observed on the hydrides as illustrated in FIGS. 5B and 5D which use ¹⁵N-Py. In contrast, the hydride signals observed in ¹⁴N-SABRE experiments (FIGS. 5A and 5C) are purely in-phase.

FIG. 5 contrasts ¹H hyperpolarization levels observed on ¹⁵N-Py versus those on ¹⁴N-Py. ¹H-SABRE on ¹⁵N-Py is less effective than that on ¹⁴N-Py regardless of whether the experiments are directed to ¹H hyperpolarization (SABRE at ˜6±4 mT, FIGS. 5A and 5B) or hyperpolarization transfer to ¹⁵N (SABRE in the magnetic shield, FIGS. 5C and 5D). These experiments illustrate that polarization transfer strategies (e.g., ¹H→¹⁵N via INEPT) may not be as effective as the direct ¹⁵N-hyperpolarization in the SABRE-SHEATH. While ¹⁵N-Py in methanol was used as a SABRE substrate, this method in principle can be applied (i) to other biomolecular contrast agents with ¹⁵N spin label, (ii) with heterogeneous catalyst, and (iii) in aqueous media.

A. Catalyst Activation and Effect of O₂

The [IrCl(COD)(IMes)] catalytic complex with Py substrate requires an initial activation with H₂ to eliminate the COD moiety and form the hexacoordinate Ir-hydride complex. This catalyst activation was monitored by in situ SABRE, a process that typically takes 10-20 min. FIG. 6A and FIG. 6B demonstrate the conventional low-field (achieved via para-H₂ exchange at 6±4 mT) SABRE proton NMR spectroscopy and corresponding NMR spectrum of the thermal reference. ¹H hyperpolarization levels are generally suppressed when using ¹⁵N-Py vs natural abundance Py. Nevertheless, signal enhancements of ˜140 for ortho-protons of ¹⁵N-Py were observed under these conditions.

Additional experiments exhibited an unexpected dependence on the presence of residual oxygen in the sample. When a SABRE-SHEATH experiment was attempted on a freshly (and fully) activated catalyst/¹⁵N-Py mixture (FIG. 6C), ¹⁵N P enhancements (ε≈300) were observed. Equilibrium ¹⁵N P is ˜10 times lower than that of ¹H due to the large difference in their gyromagnetic ratios.

Therefore, ¹⁵N P values achieved initially in SABRE-SHEATH experiments were lower than the corresponding ¹H P in conventional low-field SABRE experiments (e.g., FIG. 6B), highlighting the practical challenges of observing efficient SABRE-SHEATH hyperpolarization. Subsequent experiments showed that this reduced efficiency was related to the sample's exposure to air, affording an opportunity to greatly improve the resulting ¹⁵N polarization. Indeed, additional para-H₂ bubbling during the next 20 min (with a ˜20% duty cycle, i.e., with bubbling “on” for ˜30 s and “off” for ˜2 min at ˜6 atm of para-H₂ at a flow rate of ˜1 mL·atm·s⁻¹) resulted in significantly improved efficiency of the SABRE-SHEATH experiment. For example, FIG. 6D shows a ¹⁵N NMR spectrum taken from a SABRE-SHEATH HP sample, with ¹⁵N P ε≈3600. Yet subsequent (re)exposure of this sample to air (via air bubbling for ˜5 s) resulted in significant reduction of SABRE-SHEATH efficiency to ε≈185 (FIG. 6E). However, renewed para-H₂ bubbling (repeating the cycle described above a few times) resulted in a full recovery of the SABRE-SHEATH hyperpolarization efficiency, as depicted in FIG. 6F. Bubbling with para-H₂ for an extended period of time does not appear to change the expected ¹⁵N hyperpolarization level for any reason other than removing oxygen. Once the oxygen has been removed, the subsequent ¹⁵N SABRE-SHEATH experiments may generate a reproducible level of ¹⁵N hyperpolarization, regardless of the magnitude of the delay (during which para-H₂ bubbling was stopped) between the individual experiments (even when the delay was changed from 1 min to 1 h). Taken together, these results likely indicate that residual O₂ in the catalyst/¹⁵N-Py methanol-d₄ solution may be detrimental to the efficiency of SABRE-SHEATH (performed in microtesla fields) compared to that of conventional low-field (¹H, millitesla) SABRE. O₂ is a well-known paramagnetic relaxation source that has been shown to significantly reduce T₁ of HP ¹²⁹Xe, particularly in low magnetic fields.

B. Effect of Para-H₂ Pressure and Flow Rate

The maximum achieved ¹⁵N P of ¹⁵N-Py described herein was ˜10%, corresponding to F z 30,000 at the time of signal detection in the 400 MHz NMR spectrometer (FIG. 7A-C). The actual initial ¹⁵N polarization created within the shield prior to sample transfer is likely even higher, because of T₁ relaxation losses suffered in transit (requiring ˜5 s). The respective effects of para-H₂ pressure and flow rate could not be reliably discriminated using the flow meter because its throughput (in mL·atm·s⁻¹) is proportional to the product of volume and pressure per unit time. As a result, the same setting of the flow meter at two different pressures would result in two different mass flow rates measured in standard cubic centimeters per minutes (sccm). Therefore, a digital mass-flow controller regulating flow irrespective of bubbling pressure was utilized instead for these measurements, where the flow rate was varied at different pressures resulting in isobar curves (FIG. 7D).

The effect of the pressure is negligible at flow rates of ≦10 sccm in the range of the para-H₂ pressures studied, suggesting that in this regime the quantity of delivered para-H₂ per unit of time may be the limiting factor, not the para-H₂ pressure. ¹⁵N SABRE-SHEATH (and thus ¹⁵N P_(max)) generally rose with increasing flow rate. The growth of the ¹⁵N signal with increasing flow rate (and the quantity per unit time of delivered para-H₂ acting as source of nuclear spin hyperpolarization) was most significant in the regime of low flow rates (˜20 sccm and below, FIG. 7D). Further increase in the flow rate (above ˜20 sccm) may have a diminishing return, likely because hydrogen mass transport across the gas-liquid interface may become a limiting factor. As such, the introduced para-H₂ gas is exchanging with the liquid less efficiently. This is illustrated in the 2.7 atm isobar, where the increase in the flow rate eventually leads to the abnormal decrease of the ¹⁵N NMR signal. This behavior may be caused by the gas bubble dynamics in the NMR tube, because the volume of the gas at low pressure (at the same flow rate in sccm) is greater, which resulted in larger bubbles and inefficient mixing of para-H₂ gas and its transfer into the liquid phase. Indeed, the isobars at 1.0 and 2.7 atm produced lower signal at higher flow rates when compared to those at 5.1 and 7.1 atm. Thus, higher pressure is still more desirable to maximize ¹⁵N signal (and ¹⁵N P), but from the perspective of more efficient gas mixing and para-H₂ delivery (moles per unit of time) to the catalyst (in this setup using para-H₂ bubbling in the NMR tube). Therefore, such bubbling SABRE-SHEATH hyperpolarization setups may benefit from operation at significantly higher para-H₂ pressures to maximize the amount of para-H₂ available for SABRE processes. Furthermore, access of the Ir-hydride complex to para-H₂ (delivery of sufficient quantity of para-H₂ to Ir-hydride centers to maintain their HP state for further polarization transfer to heteronuclear sites of substrates) is a useful determining factor for increasing the efficiency of SABRE-SHEATH and maximizing the payload of HP agent.

C. Effect of Temperature

The reaction temperature may modulate the residence time of both the Py substrate and para-H₂, thereby altering exchange rates. Correspondingly, previous studies of conventional low-field SABRE have observed temperature dependences of SABRE hyperpolarization levels. FIG. 7E demonstrates an explicit temperature dependence of ¹⁵N SABRE-SHEATH polarization, with greater signal enhancements measured at lower temperatures. While others have identified that for ¹H SABRE the performance for this catalyst peaks at >40° C. in methanol-d₄, the discrepancy may be explained by several factors, including that (i) higher para-H₂ pressures (and consequently solution concentrations) were used and (ii) the interactions (the relevant spin-spin couplings) leading to NMR hyperpolarization in homonuclear (for proton SABRE hyperpolarization) and heteronuclear (for SABRE-SHEATH ¹⁵N hyperpolarization) are different, possibly giving rise to differing useful residency times for SABRE hyperpolarization.

D. Effect of Magnetic Field on ¹⁵N T₁

T₁ measurements were performed by inducing ¹⁵N SABRE-SHEATH hyperpolarization in the magnetic shield, which was followed by a variable delay for polarization decay in the magnetic shield (microtesla), in the fringe field of the main magnet (˜6 mT), or in the 9.4 T field of the magnet. Representative corresponding data sets showing the dependence of the NMR signal on the delay time at these fields are provided in FIG. 7F, exhibiting the overall trend: ¹⁵N T₁ ^(9.4T)>¹⁵N T₁ ^(6 mT)>¹⁵N T₁ ^(μT).

E. Effect of ¹⁵N T₁ in Microtesla Fields on % P

As indicated above, the ¹⁵N T₁ values were lowest in the T field. T₁ may modulate the build-up rate and the maximum attainable polarization, as can be seen in a dilution series (6 mM/100 mM, 1.2 mM/20 mM, and 0.24 mM/4 mM for the fixed [catalyst]/[¹⁵N-Py]ratio) shown in FIG. 8A, where μT T₁ gains are correlated with gains in P_(max) (defined as ¹⁵N P after SABRE-SHEATH polarization accumulation for a period of time greater than 3T₁, FIG. 8E). While further dilution led to additional T₁ gain (0.048 mM/0.8 mM), there may be other parameters (such as the residence times) that are affected by this extreme dilution, which results in significantly lower P_(max) (FIG. 8A). FIG. 8B provides additional evidence showing the trends for P_(max) and T₁ for solutions with fixed [catalyst] and variable ([¹⁵N-Py]([catalyst]/[¹⁵N-Py]ratio was varied). While the μT T₁ remained at approximately the same level of ˜10 s, the increase in [¹⁵N-Py]resulted in the corresponding decrease of P_(max) (FIG. 8F). FIGS. 8C and 8D show the trends of P_(max) and T₁ as a function of [catalyst] at fixed concentrations of [¹⁵N-Py] of 100 mM and 20 mM. Accordingly, multiple effects (e.g., T₁∝[catalyst]⁻¹, P_(max)∝[catalyst]/[¹⁵N-Py]) may cause changes in P_(max) in a complex fashion. These results highlight the underlying factors that must be considered when attempting to maximize the hyperpolarization level P_(max), which is a useful deliverable for biomedical application using HP contrast agents.

F. ¹³C SABRE-SHEATH

Hyperpolarization of aromatic ¹³C sites of ¹⁵N-Py via SABRE in general may be useful due to (i) greater ¹³C natural abundance vs ¹⁵N, (ii) more readily available detection hardware, and (iii) better detection sensitivity. However, since SABRE-SHEATH relies on the J-coupling between exchangeable protons of Ir-hydride and the target nucleus, its efficiency may be reduced because the requisite long-range (three-, four-, and five-bond) J-couplings are weak. FIG. 9 shows the comparison between conventional (low-field) and SABRE-SHEATH hyperpolarization processes for ¹³C, demonstrating that the expected antiphase signatures seen in low-field SABRE can indeed be collapsed into inphase NMR peaks (split by J¹ _(CH) spin-spin couplings) by SABRE-SHEATH. However, the achieved ¹³C signal enhancements were marginal, (ε=7 or below). Furthermore, the enhancement values for three magnetically inequivalent carbon sites of the Py molecule were in accord with the range of J coupling interactions between aromatic carbons and Ir-hydride protons (ε(J³)>ε(J⁴)>ε(J⁵) for ortho-, meta-, and para-positions. An adequate field-cycling scheme for increasing ¹³C hyperpolarization levels may be determined that is suitable for utilizing ¹³C SABRE-SHEATH. In addition, double-resonance experiments (for polarization transfer from ¹H or ¹⁵N to ¹³C) may also more efficiently hyperpolarize ¹³C spins via SABRE.

4. APPLICATIONS OF SABRE-SHEATH METHODS

A. 15N MRI

The demonstrated % P of ¹⁵N by the SABRE-SHEATH method is equal to or greater than ¹⁵N hyperpolarization achieved by d-DNP and PHIP methods, yet requires only seconds (vs tens of minutes to hours) of hyperpolarization time. The easy access to ¹⁵N hyperpolarization by SABRE-SHEATH prompted a feasibility study of HP ¹⁵N MRI. A slice-selective 2D ¹⁵N MR imaging experiment was performed using a preclinical 4.7 T MRI scanner (FIG. 10B). A modified setup was used to hyperpolarize ˜1.2 mL of solution containing 20 mM ¹⁵N-Py, corresponding to ˜24 μmol of ¹⁵N Py hyperpolarized to P of ˜1% at the time of the detection after a ˜30 s long transfer from the magnetic shield to the bore of the 38 mm i.d. ¹⁵N volume coil of a triple-resonance (¹H/¹⁵N/³¹P) RF probe (FIG. 10A). The modified setup utilized a high-pressure HPLC column (Western Analytical Products, Lake Elsinore, Calif., USA, item no. 006SCC-06-15-FF; rated to ˜30 atm), with the bottom of the column directly connected to the para-H₂ supply from the flow meter via ⅛ in. o.d. PTFE tubing. The top (exit) port was connected to the gas exhaust without any modification of the HPLC column. Para-H₂ was bubbled through the standard unmodified filter of this HPLC column from the bottom port, and used H₂ gas exited through the top of the HPLC column. It was possible to detect both free and exchangeable ¹⁵N Py resonances after >20 min long catalyst activation using ˜9.5 atm of para-H₂ pressure. Moreover, an axial 2D ¹⁵N MR image with 2×2 mm² spatial resolution was successfully acquired showing HP liquid placed inside a 6.6 mm i.d. high-pressure HPLC column. Furthermore, this image was acquired in ˜0.4 s, demonstrating the feasibility of subsecond ¹⁵N MRI of HP contrast agents. The detection sensitivity of ¹⁵N HP compounds can be further enhanced by implementation of MRI pulse sequences yielding more SNR (e.g., balanced steady-state free precession (bSSFP)). The long-lived ¹⁵N hyperpolarization can potentially also be transferred to protons for more efficient indirect detection. This practice could boost sensitivity by approximately 10-fold because the detection sensitivity is directly proportional to the gyromagnetic ratio γ and γ(¹H)≈10γ(¹⁵N). While indirect proton imaging may be challenging due to the background signal arising from water protons in vivo, low-field HP MR, which can be more sensitive than high-field MRI of HP agents, does not suffer from this shortcoming because at very low fields (e.g., 47 mT) the proton background signal is significantly attenuated. Additionally, polarization transfer schemes that enable indirect proton detection of ¹⁵N HP contrast agents can enable partial polarization transfer from ¹⁵N (storage nucleus with high T₁) to ¹H (detection nucleus with best read-out sensitivity) to enable acquisition of multiple ultrafast (<1 s) images to trace not only the distribution of the contrast agents, but also the kinetics of uptake, metabolism, and other in vivo processes.

While ¹⁵N detection hardware and MRI pulse sequences are not commonplace in clinical settings, the indirect proton detection described above can be used instead for the detection of ¹⁵N HP contrast agents produced by SABRE-SHEATH. Furthermore, more advanced indirect-detection methods do not require any heteronuclear hardware, which may allow RF excitation and detection to be performed only on the proton channels commonly available on all MRI scanners. The latter characteristic thus obviates the requirement for dedicated ¹⁵N channels on MRI scanners and can potentially enable widespread use of ¹⁵N HP contrast agents on conventional MRI scanners, requiring only a software upgrade.

B. Probes for pH Sensing and Mapping

Py and other aromatic N-heterocycles, which are already amenable to SABRE hyperpolarization, represent the fundamental molecular frameworks for many classes of biologically relevant compounds: DNA and RNA bases, vitamins, and numerous drugs and drug building blocks. Therefore, a number of potential HP contrast agents can be employed where N sites amenable to ¹⁵N SABRE-SHEATH can serve as hyperpolarization storage sites for imaging in vivo processes. For example, nicotinamide is linked to many diseases including Alzheimer's disease, cancer, and anxiety, and therefore may be a useful HP probe for these diseases. Py-based HP ¹⁵N agents have been shown useful for pH sensing using the d-DNP hyperpolarization method. This capability is enabled by the large ¹⁵N chemical shift change (>70 ppm) induced by protonation, which causes the ¹⁵N chemical shift to have a straightforward dependence on pH. Non-HP agents using the same principle have already been successfully demonstrated in vivo, with the most prominent application in cancer imaging, because many types of tumors are known to be slightly acidic. Therefore, non-invasive pH sensing and mapping are potential biomedical applications for ¹⁵N SABRE-SHEATH in the context of molecular in vivo imaging. To date, ¹⁵N-SABRE-SHEATH produces ¹⁵N-Py and ¹⁵N-nicotinamide with ˜6 times greater hyperpolarization levels compared to those achieved by d-DNP with a much more rapid hyperpolarization process (˜1 min vs ˜2 h), highlighting the advantages of ¹⁵N SABRE-SHEATH for this class of compounds.

In addition, nitrogen-containing compounds such as pyridine, nicotinamide and others can be enriched with ¹⁵N using simple chemistry that either allows direct heteroatom replacement with ¹⁵N isotope or through a ring opening and closure, frequently using ¹⁵NH₄Cl as a very cheap source of spin label. As a result, the labor-intensive de novo synthesis of complex ¹⁵N biomolecules can be largely obviated. Therefore, the ¹⁵N isotopic enrichment required for ¹⁵N SABRE-SHEATH may produce inexpensive contrast agents. Combined with the very simple setup and instrumentation required for SABRE-SHEATH, it may enable fast, high-throughout, scalable, and low-cost production of HP ¹⁵N contrast agents.

In vivo use of HP contrast agents, including ¹⁵N agents, typically requires their administration in aqueous media free from catalysts and activation byproducts. Relevant to this work, the recent reports of heterogeneous SABRE catalysts, continuous SABRE hyperpolarization and aqueous SABRE catalysis are highly synergistic with SABRE-SHEATH for production of HP contrast agents on demand with suitable in vivo administration. Moreover, heterogeneous SABRE catalysts provide an additional benefit of potential catalyst recycling to further minimize the costs associated with catalyst preparation and waste disposal.

C. Hyperpolarization of Neat Liquids

SABRE-SHEATH techniques can also achieve hyperpolarization of neat liquids—each comprised only of an otherwise pure target compound and millimolar concentrations of dissolved catalyst, without any additional diluting solvent. In principle, such liquids could be used directly as hyperpolarized MRI contrast agents; the use of organic solvents is obviated, and a greater payload for the concentrated agents is observed.

¹H SABRE (conducted conventionally at ˜6 mT field) yielded very small signal enhancement of ε≈4 (FIG. 11B). The ¹⁵N signal exhibited a strong, nearly linear dependence on the flow rate of para-H₂ in the range studied (the flow-rate of 150 standard cubic centimeters (sccm) represents an experimental limitation of the setup at ˜7 atm), which was metered independently of the applied pressure and hence solution para-H₂ concentration (FIG. 11C). The ¹⁵N signal enhancement was approximately independent of the para-H₂ pressure (and solution concentration according to Henry's law), indicating that the flux of the available para-H₂ spin bath (the source of spin order) was indeed the limiting factor; that is, the potential possibility of exchanging more para-H₂ per unit time would likely yield greater ¹⁵N signal enhancements. Larger para-H₂ exposure can be attained by higher pressures and smaller bubbles/better gas-phase-liquid-phase mixing.

One effect limiting the maximum achievable hyperpolarization is spin-lattice relaxation. The ¹⁵N spin-lattice relaxation time is significantly shorter in microTesla fields than at high field (9.4 T), 5.5±0.5 versus 60.8±0.6 s, respectively (FIG. 11E and FIG. 11F), and such efficient relaxation results in SABRE-SHEATH ¹⁵N enhancements reaching significantly lower steady-state levels after the hyperpolarization procedure. The supply of para-H₂ is limited because only ˜0.1 mmol/s pass through the tube at the maximum flow rate of 150 sccm, whereas 90 mM catalyst (in ˜0.4 mL volume) alone is capable of exchanging of ˜0.2 to 0.4 mmol/s of H₂ because the hydrogen exchange rate is ˜5-10 per second. However, Ir-hydride protons do not have 100% exchange efficiency with para-H₂ gas. Instead, this exchange is further constricted by at least two bottlenecks: (i) exchange of H₂ between gas and liquid phases and (ii) exchange of dissolved para-H₂ with Ir-hydride. Equilibrium H₂ concentration in organic solvents is <4 mM/atm; that is, even at the maximum para-H₂ pressure used (˜7 atm), para-H₂ concentration is <30 mM, at least three times lower than that of the Ir-hydride catalyst at 90 mM concentration. Moreover, when para-H₂ singlet spin order is transferred to Py via SABRE, para-H₂ becomes ortho-H₂, manifesting as an HP byproduct, and this resulting ortho-H₂ can no longer serve as a source of hyperpolarization in conventional ex situ SABRE. Furthermore, hydride proton exchange rates are on the order of 10 per second; therefore, each para-H₂ molecule on average experiences >30 exchanges per second under these conditions ([catalyst] of ˜90 mM results in the total of ˜900 para-H₂ exchanges per second for <30 mM [para-H₂] dissolved). The main implication of the above two bottlenecks, the fast hydrogen exchange and the limited flux of para-H₂ gas, is that [ortho-H₂]>>[para-H₂]. Furthermore, the additional feature of the complex interplay of microTesla ¹⁵N effective T₁ and limited access to para-H₂ is that it should imply the existence of a useful catalyst concentration and a useful ratio of Py to catalyst concentrations.

The additional evidence that the finite para-H₂ spin bath is limiting the SABRE processes is also seen when n.a. Py (ε˜2900) was replaced by 99% ¹⁵N enriched Py (15N-Py, ε≈33), Table 1. ¹⁵N signal enhancement decreases by nearly 2 orders of magnitude (88-fold), while the concentration of ¹⁵N spins is increased by 278 fold (=1/0.0036); however, the total Py concentration and quantity is maintained the same. As such, the observed signal (given by the product of [¹⁵N] and E) only decreases by 3 fold when working with n.a. Py. Another aspect is that ¹⁵N microTesla effective T₁ of ¹⁵N-Py (10.2±1.1 s) is longer than that of n.a. Py (5.5±0.5 s); see Table 1.

TABLE 1 Summary of Results with Natural Abundance (n.a.) Pyridine (Py), Py-d₅, ¹⁵N—Py, and their mixtures ¹⁵N ortho- [¹⁵N] ¹⁵N ε @ effective ¹⁵N T₁ [¹H] ¹H ε @ [catalyst] (mM) 9.4 T T₁ μT (s) 9.4 T (s) (mM) 9.4 T (mM) 1) Py (n.a.)^(b) ~45 ~−2900  5.5(0.5) 60.8(0.6) ~25000 ~−4.2 ~90 2) Py-d₅ (99.5% d) ~45 ~−850 2.2(0.1) 74.3(2.9) ~125 ~−60   ~90 3) ¹⁵N—Py ~12500  ~−33 10.2(1.1  66.8(0.5) ~25000 ~−0.3 ~90 4) catalyst activated ~2000 ~−520 10.1(0.8)  69.9(0.3) ~4000 ~−2.6 ~90 with ¹⁵N—Py, then Py-d₅ added 5) catalyst activated ~1800 ~−400 15.1(2.3)  73.2(0.3) ~3600 ~−2.7 ~90 with Py-d₅, then ¹⁵N—Py is added 6) catalyst activated ~1800 ~−450 9.9(1.1) 70.0(0.3) ~3600 ~−1.0 ~90 with ¹⁵N—Py, then in n.a. Py is added 7) catalyst activated ~1800 ~−380 8.2(1.1) 69.9(0.3) ~3600 ~−0.6 ~90 with n.a. Py, then ¹⁵N—Py is added ^(b)Conducted with >90% para-H₂, while the rest of the data is collected using 65-75% para-H₂, resulting in ~30-40% lower signal enhancements compared with those shown in row 1. Note that the data for pairs 2 and 3, 4 and 5, and 6 and 7 were respectively collected on the same day at the same level of para-H₂ enrichment and stored in a pressurized aluminum cylinder as previously described (and thus should be directly comparable).

Furthermore, achieving such significantly greater (by 88-fold)¹⁵N ε in n.a. Py with respect to ¹⁵N-Py under the conditions of limited access to para-H₂ has a significance for the mechanistic understanding of the SABRE-SHEATH phenomenon. In particular, this result indicates that the hyperpolarization para-H₂ spin bath is not depleted when the exchanging substrate on Ir-hydride catalyst is ¹⁴N-Py. If no interaction between para-state of hydride and ¹⁵N-Py occurs (e.g., the exchanging partner is ¹⁴N-Py), para-state of hydride should exchange back into para-H₂ with preservation of the para-H₂ hyperpolarization pool (FIG. 12B). As such, the spin order residing in the entire pool of para-H₂ can be selectively channeled to hyperpolarize ¹⁵N nuclei of the exchangeable substrate (e.g., n.a. Py) rather than being depleted by rapidly relaxing ¹⁴N sites acting as hyperpolarization sinks. This allows achieving relatively high levels of ¹⁵N hyperpolarization (e.g., P¹⁵N≈1%), even when performing SABRE-SHEATH in the high substrate concentration regime encountered with effectively neat solutions and when the supply and transport of para-H₂ are restricted. The ¹⁴N species likely do not deplete the para-H₂ state because the quadrupolar relaxation rate of the ¹⁴N spins is faster than the J-coupling interactions that would otherwise transfer hyperpolarization to the target spins; hence, the ¹⁴N spins are effectively (self)decoupled from the bound para-H₂.

The theoretical model of SABRE-SHEATH described above, while appropriate for ¹⁵N-enriched substrates, no longer applies for n.a. Py, and an amended theoretical model is presented to describe the polarization transfer in the n.a. case. The original model invoked an AA′BB′ four spin system, where AA′ represents the parahydrogen-derived hydrides and BB′ represents the equatorial (exchangeable) ¹⁵N spins depicted in FIG. 13A. For this case, the magnetic field must be chosen such that at least one of the following resonance conditions are met:

Δv _(HN) =|J _(HH) +J _(NN)−(J _(HN) +J _(HN′))/2|  (6)

Δv _(HN) =|J _(HH) −J _(NN)|  (7)

When these resonance conditions are met, then the N—H J couplings drive the hyperpolarization transfer; specifically, the term (J_(HN)−J_(HN′))/2 determines the rate of hyperpolarization transfer. However, in the n.a. Py case, this spin system has to be adjusted because in 99.64% (=100−0.36%) of species that contain one ¹⁵N spin the adjacent equatorial species is a ¹⁴N spin, not ¹⁵N; therefore, the model is amended to an AA′B three-spin system, where AA′ represents the parahydrogen derived hydrides and B represents the ¹⁵N spin. The ¹⁴N spin can be ignored because the strong quadrupolar interaction decouples the ¹⁴N spin from the depicted spin systems. As a result, the resonance condition for the new model is

Δv=|J _(HH)−(J _(HN) +J _(HN′))/4|  (8)

In the three-spin system it is also the NH-J couplings that drive the hyperpolarization transfer; here it is specifically the term (J_(HN)−J_(HN′))/(2√2), which determines the rate of hyperpolarization transfer.

Next, conventional homonuclear ¹H-SABRE experiments were performed. The ¹H signal enhancements, which were determined in the milliTesla regime (Table 1) followed the general trend seen for ¹⁵N SABRE-SHEATH, with signal enhancements being greater when the proton spin bath of to be-hyperpolarized substrate was reduced. For example, ε≈(−)60 was observed for Py-d₅ versus ε≈(−)4.2 for n.a. Py, which is in agreement with the previous results above.

Because ¹⁴N and other quadrupolar nuclei may act as direct or indirect hyperpolarization sinks (e.g., polarization transfer from Ir-hydride protons to ¹⁴N, D, etc. or from ¹⁵N (after hyperpolarization transfer from para-H₂) to ¹⁴N, D, etc.) at low magnetic fields (analogous to interaction between ¹²⁹Xe and ¹³¹Xe in xenon lattices), and because the local molecular environment can significantly alter the ¹⁵N effective T₁ in the microTesla field regime, ¹⁵N SABRE-SHEATH of deuterated Py (Py-d₅) was studied as well as various mixtures of ¹⁵N-Py and Py-d₅ with ¹⁵N-Py and n.a. Py (Table 1). Accordingly, the Py type (n.a. Py, Py-d₅, or ¹⁵N-Py) used during the activation period determined the spin configuration of Py in the axial nonexchangeable position of the hexacoordinate Ir-hydride complex, whereas the abundance of the Py type in the mixture determines the most probable type of exchangeable Py in the two equatorial positions. Deuteration of to be-polarized ¹⁵N-substrate had the most detrimental effect on microTesla ¹⁵N effective T₁, a decrease from 5.5±0.5 to 2.2±0.1 s for n.a. Py versus Py-d₅ (row 1 vs row 2 of Table 1). A similar but slightly larger decrease (from ε≈(−)2900 to (−)850) was observed for the corresponding SABRE-SHEATH ¹⁵N enhancement values, indicating that the majority of deuterium-induced depolarization was due to indirect transfer, for example, from ¹⁵N to ²H. However, the direct depolarization losses may have a significant contribution as well. For example, in cases when nondeuterated ¹⁵N-Py was used in combination with Py-d₅, microTesla ¹⁵N effective T₁ is greater when the catalyst was first activated with Py-d₅ versus that when catalyst is first activated with ¹⁵N-Py (15.1±2.3 versus 10.1±0.8 s), but the ¹⁵N signal enhancements were somewhat lower (ε≈(−)400 vs (−)520), indicating that at least some polarization losses occurred on the hyperpolarized Ir-hydride due to the presence of deuterium in the catalyst structure.

The effect of ¹⁴N presence in the catalyst structure as a potential relaxation or polarization sink was studied by comparing two samples prepared using a mixture of ¹⁵N-Py and n.a. Py (consisting mostly of ¹⁴N-Py; rows 6 and 7 of Table 1). Activation of SABRE catalyst with ¹⁵N-Py versus n.a. Py resulted in a slight increase in the microTesla ¹⁵N effective T₁ (9.9±1.1 s vs 8.2±1.1 s) as well as the ¹⁵N signal enhancement (ε≈(−)450 vs (−)380), indicating that ¹⁴N presence may act as a weak relaxation or polarization sink, likely through contributions from both mechanisms; that is, direct transfer from hyperpolarized Ir-hydrides and from exchangeable ¹⁵N-Py.

Accordingly, the ¹⁵N SABRE-SHEATH of neat liquids is an advantageous tool for efficient hyperpolarization of ¹⁵N spins, particularly at their low natural abundance level. One potential use is for rapid compound screening, demonstrated on a series of picolines and lutidines shown in FIG. 14. It was determined that the presence of a methyl group in position 2 or 6 results in no detectable ¹⁵N hyperpolarization via SABRE-SHEATH, whereas the substituents in other positions result in ¹⁵N signal enhancements levels similar to those of Py. Steric hindrance induced by the presence of methyl groups in ortho positions significantly alters the time scale of the SABRE exchange process or reduces the association constant.

Picolines and lutidines were chosen because pH-mediated protonation of N-heterocylic compounds can be useful for in vivo pH imaging using conventional proton-based non-hyperpolarized sensing, where the difference in ¹⁵N chemical shift induced by the agent protonation can be useful for pH imaging provided that the agent's pKa is in the physiologically relevant range. ¹⁵N centers of the Py class screened here were identified as promising hyperpolarized pH sensors with potential biomedical application to noninvasively image local variances in tissue pH. Unlike previously demonstrated pH imaging with hyperpolarized H¹³CO₃ ⁻/¹³CO₂ that relies on the measurement of the ratio of two exchanging species, pH imaging using hyperpolarized ¹⁵N heterocycles relies on the modulation of ¹⁵N chemical shift, which changes by up to 100 ppm between protonated and deprotonated states. This feature offers a significant sensitivity advantage because only one species requires detection (ratiometric measurements are not needed), and low signal-to-noise ratio would not affect the accuracy of the measurement because the chemical shift reports on the pH. Moreover, hyperpolarized ¹⁵N sites have significantly longer T₁ in aqueous media (>30 s) compared with ¹³C bicarbonate (˜10 s), which can also be a significant advantage for in vivo applications (especially relevant for applications involving cancer, given the known hallmarks of elevated glycolysis and mildly acidic microenvironments). The ¹⁵N signal enhancements reported in FIG. 14 may be increased through improved apparatus design, allowing for better access to the hyperpolarization source of para-H₂ (as well as reduced transit times to high field for detection). Moreover, the combination of heterogeneous SABRE catalysts with the method presented here may allow preparation of pure hyperpolarized liquids because such solid phase catalysts can be separated and recycled. Nevertheless, the reported ¹⁵N signal enhancement values are already comparable to ¹⁵N enhancements previously reported using dissolution DNP technology and a commercial DNP hyperpolarizer. However, the method reported here achieves the steady-state maximum hyperpolarization level in <1 min without sophisticated equipment, versus ˜2 h using expensive DNP hyperpolarizers. SABRE for hyperpolarization of ¹⁵N pH sensors can directly lead to useful in vivo applications because the ¹⁵N SABRE-SHEATH procedure is a relatively simple process and because in vivo pH sensors are useful in metabolic biomedical applications.

Imidazole-based pH sensors have been known in the context of proton Magnetic Resonance Spectroscopy (MRS). The ¹⁵N chemical shift of imidazole changes by more than 30 ppm upon protonation (FIG. 15). Because pKa of imidazole is ˜7.0 and because it is a relatively non-toxic molecule, it may be a potent pH sensor as a ¹⁵N hyperpolarized contrast agent. It is amenable to SABRE-SHEATH hyperpolarization, as can be seen in FIG. 15 with ¹⁵N signal enhancement of >1,000 with already achievable hyperpolarization level of ˜1% in the initial proof-of-principle demonstration (FIG. 15).

5. EXAMPLES SABRE Catalyst and Sample Preparation

The SABRE samples were prepared by the addition of an aliquot of ¹⁵N enriched (Sigma-Aldrich, P/N 486183) or natural-abundance Py to a solution of catalyst precursor, resulting in desired concentrations of Py and catalyst. The SABRE catalyst was created using the precursor [IrCl(COD)(IMes)]. The catalyst precursor activation was monitored via in situ detection of HP intermediate Ir-hydride species within a 9.4 T NMR spectrometer by proton NMR spectroscopy using the SABRE effect. Once fully activated, SABRE experiments in the magnetic shield (microtesla) or in the low magnetic field (fringe field of the 9.4 T magnet) of 6±4 mT (FIG. 1) were performed. Some samples were prepared by taking an aliquot of already-activated sample (Py with catalyst) and performing a series of dilutions (one to three) to achieve the desired concentrations. Perdeuterated methanol (methanol-d₄) was used as a solvent for all experiments. >90% para-H₂, was used for all experiments.

Experimental SABRE Setup at 9.4 T

A freshly prepared sample containing the Ir precursor catalyst and Py in CD₃OD was placed inside a 5 mm medium-wall NMR tube (3.43 mm i.d.) for SABRE hyperpolarization. Normal H₂ gas or para-H₂ gas was bubbled through the methanol-d₄ solution via 1/16 in. o.d. ( 1/32 in. i.d.) tubing inside the NMR tube as shown in FIG. 1. A flow-meter was used to regulate the gas flow at the rate of ˜1 mL·atm·s⁻¹. The bubbling time and para-H₂ pressure varied from ˜1 to 60 s and from 1 to ˜7 atm, respectively, for SABRE experiments. Activation by H₂ bubbling used longer time periods and 1 atm pressure as described earlier. For the in situ SABRE experiments at 9.4 T, para-H₂ bubbling occurred inside the NMR magnet, and the signal was acquired (3±2 s) after the bubbling was stopped. For low-field SABRE experiments and SABRE-SHEATH experiments, para-H₂ bubbling occurred outside of the NMR detector (in the 6±4 mT fringe field of the NMR magnet) or inside the magnetic shield, respectively (FIG. 1). The sample was manually shuttled to the NMR magnet (9.4 T) into the detection coil, and the signal was recorded with typical transit times of 5±2 s. The experimental setup was modified in studies of ¹⁵N SABRE-SHEATH signal dependence on the flow rate at four different pressure values by replacing the flow meter (FIG. 1A) with a mass flow controller (Sierra Instruments, Monterey, Calif., model no. C100L-DD-OV1-SV1-PV2-V1-S0-C0).

The NMR signal reference samples for ¹³C and ¹⁵N were loaded in standard 5 mm (4.14 mm i.d.) NMR tubes. All NMR experiments were conducted with a single-scan acquisition (90° excitation RF pulse) using 400 MHz Bruker Avance III spectrometer unless noted otherwise.

Calculations of NMR Polarization Enhancements at 9.4 T

Calculation of P enhancement (ε) and the % P were performed as follows: ε(1H) was calculated as the ratio of NMR signals from HP signal (S_(HP)) vs thermally polarized equilibrium signal from the same sample at 9.4 T (S_(THER)): ε(¹H)=S_(HP)/S_(THER). The equilibrium signal intensities for ¹⁵N and ¹³C samples were too low, and signal averaging was impractical due to excessively long (≧1 min) T₁ values. Therefore, external signal reference samples of 12.5 M ¹⁵N-Py and neat methanol (24 M with ˜1.1% natural abundance of ¹³C isotope) were employed instead. Heteronuclear enhancement values were thus calculated as follows: ε(¹⁵N or ¹³C)=(S_(HP)/S_(REF))(C_(REF)/C_(HP))(A_(REF)/A_(HP)), where C_(REF) and C_(HP) are concentrations of reference and HP samples, respectively, S_(HP) and S_(REF) are integrated NMR signals of HP and references samples, respectively, and A_(REF) and A_(HP) are the corresponding cross sectional areas of these solutions. The A_(REF)/A_(HP) ratio was ˜1.85, computed as 4.142/(3.432−1.62), where 4.14 mm is the inner diameter of the standard 5 mm NMR tubes used for NMR signal referencing samples, 3.43 mm is the inner diameter of the medium-pressure tubes used for SABRE samples, and 1.6 mm is the outer diameter of the 1/16 in. PTFE tubing inserted into the medium-wall NMR tube for para-H₂ bubbling (note that (3.432−1.62) mm² corresponds to the effective solution cross-section in the medium-wall NMR tubes used for SABRE experiments, in contrast to 4.142 mm² used for signal reference samples). P was calculated as the following product: ε·P_(THER), where P_(THER) is the thermal equilibrium nuclear spin polarization of ¹H, ¹³C, or ¹⁵N nuclei at 9.4 T and 300 K (3.2×10⁻⁵, 8.1×10⁻⁶, and 3.3×10⁻⁶, respectively).

SABRE-SHEATH Neat Liquid Experiments Preparation Procedure for Neat Picolines and Lutidines

Non-activated Iridium catalyst prepared in the previous studies, [IrCl(cod)(IMes), 10 mg, 0.015 mmol, MW ˜640] was added to an Eppendorf tube followed by the addition of 0.6 mL of the corresponding pyridine analog. The Eppendorf tube was vortexed, and the homogeneous content of the tube was transferred via a glass pipette to a medium-walled NMR (5 mm medium wall precision (3.43 mm ID), NMR Sample Tube 9 in. long, Wilmad glass P/N 503-PS-9) tube equipped with the Teflon tube (0.25 in. OD, 3/16 in. ID) extension, which was approximately 7 cm long. The tube was attached to the previously described setup through a push-to-connect adapter. The sample was activated by running hydrogen or parahydrogen (para-H₂) at 5 (sccm) under the pressure of either at ˜7 atm or ˜5 atm pressure for >1 hour at hydrogen gas flow rate of <10 sccm with flow rate controlled by the mass flow controller (Sierra Instruments, Monterey, Calif., model number C100L-DD-OV1-SV1-PV2-V1-S0-C0). Change of color from dark orange to lighter yellow or reddish was observed after catalyst activation. Partial material loss was detected by the end of the activation period due to sample evaporation due to hydrogen gas bubbling to ˜0.35 mL. As a result, the final concentration of catalyst was calculated as the following: [catalyst]=10 (mg)/640 (mg/mole)/0.35 mL˜45 mM.

Preparation Procedure for Neat Pyridines

The samples with pyridine (Py) were prepared and activated in the same manner as described for the picolines and lutidines above except that four different catalyst loadings (10 mg, 13 mg, 20 mg and 40 mg) were used for natural abundance (n.a.) Py yielding the following final concentrations: ˜45 mM, ˜60 mM, ˜90 mM and ˜180 mM respectively. The solutions of ¹⁵N-Py and perdeuterated (99.5% d) Py were prepared and activated in the same fashion as described above using 20 mg of the same Ir catalyst, and yielding ˜90 mM final catalyst concentration.

¹⁵N SABRE-SHEATH Hyperpolarization

The sample solution was bubbled with para-H₂ (the period of bubbling, flow rate, and pressure were varied depending on the goal of the experiment) inside the magnetic shield (Lake Shore Cryotronics, P/N 4065). This was followed by a rapid sample transfer from the shield to Earth magnetic field followed by quenching the flow of para-H₂ and sample insertion in the bore of 9.4 T magnet and acquisition of ¹⁵N NMR spectrum. In case of the ¹⁵N T₁ measurements in the microTesla field of the magnetic shield, the para-H₂ flow was stopped while the sample remained in the shield before it was removed from the shield. The increase of the time period that the sample spent inside the shield after para-H₂ flow was stopped resulted in the decrease of the induced ¹⁵N SABRE-SHEATH hyperpolarized signal detected in the 9.4 T spectrometer, allowing to conveniently measure the effective decay of ¹⁵N hyperpolarization in the shield.

¹H SABRE Hyperpolarization

The sample tube with activated catalyst and to-be-hyperpolarized substrate is placed in the fringe field of the magnet at 6±4 mT (calibrated with gauss meter), and parahydrogen is bubbled for about 20-30 seconds. The exponential build-up constant for ¹H SABRE is about 7.4 s, and 20-30 seconds of para-H₂ bubbling is sufficient to reach the steady-state level of ¹H hyperpolarization.

The results of activation of the Ir catalyst with n.a. Py (FIG. 16), Py-d₅ (FIG. 17), ¹⁵N-Py (FIG. 18), ¹⁵N-Py followed by Py-d₅ (FIG. 19), Py-d₅ followed by ¹⁵N-Py (FIG. 20), ¹⁵N-Py followed by n.a. Py (FIG. 21), and n.a. Py followed by ¹⁵N-Py (FIG. 22) are shown in FIGS. 16-22.

For reasons of completeness, various aspects of the present disclosure are set out in the following numbered clauses:

Clause 1. A method of hyperpolarizing heteronuclei, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; and (b) applying a magnetic field to the mixture, wherein the magnetic field causes the matching of the resonance frequency of parahydrogen with the resonance frequency of the at least one hyperpolarizable heteronucleus, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus.

Clause 2. The method of clause 1, wherein the spin order is transferred during a temporary association of parahydrogen, the compound, and the catalyst while maintaining the chemical identity of the compound.

Clause 3. The method of clause 1, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are within an order of magnitude of each other.

Clause 4. The method of clause 1, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are different.

Clause 5. The method of clause 1, wherein the magnetic field has a strength of less than 50 μT.

Clause 6. The method of clause 1, wherein the magnetic field has a strength of less than 20 μT.

Clause 7. The method of clause 1, wherein the magnetic field has a strength of less than 5 μT.

Clause 8. The method of clause 1, wherein the magnetic field has a strength of about 0.1 to about 1 μT.

Clause 9. The method of clause 1, wherein the at least one heteronucleus is selected from the group consisting of ¹³C, ¹⁵N, ¹⁹F, ²⁹Si, ³¹P, ²H and ¹²⁹Xe.

Clause 10. The method of clause 1, wherein the at least one heteronucleus is ¹⁵N.

Clause 11. The method of clause 1, wherein the mixture further comprises a solvent.

Clause 12. The method of clause 11, wherein the solvent is a deuterated solvent.

Clause 13. The method of clause 1, wherein the catalyst is a heterogeneous catalyst.

Clause 14. The method of clause 1, wherein the catalyst is a homogeneous catalyst.

Clause 15. The method of clause 1, wherein the catalyst comprises a transition metal.

Clause 16. The method of clause 15, wherein the transition metal is iridium.

Clause 17. The method of clause 1, wherein the catalyst is [IrCl(COD)(IMes)].

Clause 18. The method of clause 1, wherein the catalyst is a homogeneous or heterogeneous catalyst, wherein the catalyst accommodates the simultaneous exchange of para-H₂ and heteronuclear spin center(s), and wherein the condition of spin-spin (weak or strong J) coupling between para-H₂ derived protons and heteronuclear spin center(s) is maintained.

Clause 19. The method of clause 1, wherein the compound is isotopically enriched.

Clause 20. The method of clause 1, wherein the compound is a contrast agent for an in vivo imaging technique.

Clause 21. A method of obtaining an MRI image, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; (b) applying a magnetic field to the mixture, wherein the magnetic field causes the matching of the resonance frequency of parahydrogen with the resonance frequency of the at least one hyperpolarizable heteronucleus of the compound, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; and (c) performing an MRI measurement or MR spectroscopy on the compound.

Clause 22. A method of in vivo pH sensing, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; wherein the compound has at least one pKa value of about 6 to about 9; (b) applying a magnetic field to the mixture, wherein the magnetic field causes the matching of the resonance frequency of parahydrogen with the resonance frequency of the at least one hyperpolarizable heteronucleus of the compound, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; (c) removing the catalyst from the mixture; and (d) performing an in vivo imaging measurement on the compound.

Clause 23. A method of performing an NMR experiment, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; (b) applying a magnetic field to the mixture, wherein the magnetic field causes the matching of the resonance frequency of parahydrogen with the resonance frequency of the at least one hyperpolarizable heteronucleus, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; and (c) performing an NMR measurement on the compound.

Clause 24. The method of clause 23, wherein the spin order is transferred during a temporary association of parahydrogen, the compound, and the catalyst while maintaining the chemical identity of the compound.

Clause 25. The method of clause 23, wherein the chemical structure of the compound provided in step (a) is the same as the chemical structure of the compound subject to the NMR experiment in step (c).

Clause 26. The method of clause 23, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are within an order of magnitude of each other.

Clause 27, The method of clause 23, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are different.

Clause 28. The method of clause 23, wherein the NMR experiment produces at least one enhanced signal in the NMR spectrum of the compound.

Clause 29. The method of clause 23, wherein the magnetic field has a strength of less than 50 μT.

Clause 30. The method of clause 23, wherein the magnetic field has a strength of less than 20 μT.

Clause 31. The method of clause 23, wherein the magnetic field has a strength of less than 5 μT.

Clause 32. The method of clause 23, wherein the magnetic field has a strength of about 0.1 to about 1 μT.

Clause 33. The method of clause 23, wherein the at least one hyperpolarizable heteronucleus is selected from the group consisting of ¹³C, ¹⁵N, ¹⁹F, ²⁹Si, ³¹P, ²H and ¹²⁹Xe.

Clause 34. The method of clause 23, wherein the at least one hyperpolarizable heteronucleus is ¹⁵N.

Clause 35. The method of clause 23, wherein the mixture further comprises a solvent.

Clause 36. The method of clause 35, wherein the solvent is a deuterated solvent.

Clause 37. The method of clause 23, wherein the catalyst is a heterogeneous catalyst.

Clause 38. The method of clause 23, wherein the catalyst is a homogeneous catalyst.

Clause 39. The method of clause 23, wherein the catalyst comprises a transition metal.

Clause 40. The method of clause 39, wherein the transition metal is iridium.

Clause 41. The method of clause 23, wherein the catalyst is [IrCl(COD)(IMes)].

Clause 42. The method of clause 23, wherein the catalyst is a homogeneous or heterogeneous catalyst, wherein the catalyst accommodates the simultaneous exchange of para-H₂ and heteronuclear spin center(s), and wherein the condition of spin-spin (weak or strong J) coupling between para-H₂ derived protons and heteronuclear spin center(s) is maintained.

Clause 43. The method of clause 23, wherein the compound is isotopically enriched.

Clause 44. The method of clause 23, wherein the compound is a contrast agent for an in vivo imaging technique.

Clause 45. A method of performing an NMR experiment, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; and (c) performing an NMR measurement on the compound.

Clause 46. The method of clause 45, wherein the spin order is transferred during a temporary association of parahydrogen, the compound, and the catalyst while maintaining the chemical identity of the compound.

Clause 47. The method of clause 45, wherein the chemical structure of the compound provided in step (a) is the same as the chemical structure of the compound subject to the NMR experiment in step (c).

Clause 48. The method of clause 45, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are within an order of magnitude of each other.

Clause 49. The method of clause 45, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are different.

Clause 50. The method of clause 45, wherein the magnetic field is determined by matching the resonance frequency of parahydrogen with the resonance frequency of the at least one hyperpolarizable nucleus of the compound.

Clause 51. The method of clause 45, wherein the NMR experiment produces at least one enhanced signal in the NMR spectrum of the compound.

Clause 52. The method of clause 45, wherein the magnetic field has a strength of less than 20 μT.

Clause 53. The method of clause 45, wherein the magnetic field has a strength of less than 5 μT.

Clause 54. The method of clause 45, wherein the magnetic field has a strength of about 0.1 to about 1 μT.

Clause 55. The method of clause 45, wherein the at least one heteronucleus is selected from the group consisting of ¹³C, ¹⁵N, ¹⁹F, ²⁹Si, ³¹P, ^(2H) and ¹²⁹Xe.

Clause 56. The method of clause 45, wherein the at least one heteronucleus is ¹⁵N.

Clause 57. The method of clause 45, wherein the mixture further comprises a solvent.

Clause 58. The method of clause 57, wherein the solvent is a deuterated solvent.

Clause 59. The method of clause 45, wherein the catalyst is a heterogeneous catalyst.

Clause 60. The method of clause 45, wherein the catalyst is a homogeneous catalyst.

Clause 61. The method of clause 45, wherein the catalyst comprises a transition metal.

Clause 62. The method of clause 61, wherein the transition metal is iridium.

Clause 63. The method of clause 45, wherein the catalyst is [IrCl(COD)(IMes)].

Clause 64. The method of clause 45, wherein the catalyst is a homogeneous or heterogeneous catalyst, wherein the catalyst accommodates the simultaneous exchange of para-H₂ and heteronuclear spin center(s), and wherein the condition of spin-spin (weak or strong J) coupling between para-H₂ derived protons and heteronuclear spin center(s) is maintained.

Clause 65. The method of clause 45, wherein the compound is isotopically enriched.

Clause 66. The method of clause 45, wherein the compound is a contrast agent for an in vivo imaging technique.

Clause 67. A method of hyperpolarizing heteronuclei, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; and (b) applying a magnetic field with a strength of less than 50 T to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus.

Clause 68. The method of clause 67, wherein the spin order is transferred during a temporary association of parahydrogen, the compound, and the catalyst while maintaining the chemical identity of the compound.

Clause 69. The method of clause 67, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are within an order of magnitude of each other.

Clause 70. The method of clause 67, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are different.

Clause 71. The method of clause 67, wherein the magnetic field is determined by matching the resonance frequency of parahydrogen with the resonance frequency of at least one hyperpolarizable nucleus of the compound.

Clause 72. The method of clause 67, wherein the magnetic field has a strength of less than 20 μT.

Clause 73. The method of clause 67, wherein the magnetic field has a strength of less than 5 μT.

Clause 74. The method of clause 67, wherein the magnetic field has a strength of about 0.1 to about 1 μT.

Clause 75. The method of clause 67, wherein the at least one heteronucleus is selected from the group consisting of ¹³C, ¹⁵N, ¹⁹F, ²⁹Si, ³¹P, ²H and ¹²⁹Xe.

Clause 76. The method of clause 67, wherein the at least one heteronucleus is ¹⁵N.

Clause 77. The method of clause 67, wherein the mixture further comprises a solvent.

Clause 78. The method of clause 77, wherein the solvent is a deuterated solvent.

Clause 79. The method of clause 67, wherein the catalyst is a heterogeneous catalyst.

Clause 80. The method of clause 67, wherein the catalyst is a homogeneous catalyst.

Clause 81. The method of clause 67, wherein the catalyst comprises a transition metal.

Clause 82. The method of clause 81, wherein the transition metal is iridium.

Clause 83. The method of clause 67, wherein the catalyst is [IrCl(COD)(IMes)].

Clause 84. The method of clause 67, wherein the catalyst is a homogeneous or heterogeneous catalyst, wherein the catalyst accommodates the simultaneous exchange of para-H₂ and heteronuclear spin center(s), and wherein the condition of spin-spin (weak or strong J) coupling between para-H₂ derived protons and heteronuclear spin center(s) is maintained.

Clause 85. The method of clause 67, wherein the compound is isotopically enriched.

Clause 86. The method of clause 67, wherein the compound is a contrast agent for an in vivo imaging technique.

Clause 87. A method of performing an NMR experiment, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; and (c) performing an NMR measurement on the compound.

Clause 88. The method of clause 87, wherein the NMR experiment produces at least one enhanced signal in the NMR spectrum of the compound.

Clause 89. A method of obtaining an MRI image, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; and (c) performing an MRI measurement or MR spectroscopy on the compound.

Clause 90. A method of in vivo pH sensing, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; wherein the compound has at least one pKa value of about 6 to about 9; (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; (c) removing the catalyst from the mixture; and (d) performing an in vivo imaging measurement on the compound.

It is understood that the foregoing detailed description and accompanying examples are merely illustrative and are not to be taken as limitations upon the scope of the invention, which is defined solely by the appended claims and their equivalents.

Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications, including without limitation those relating to the chemical structures, substituents, derivatives, intermediates, syntheses, compositions, formulations, or methods of use of the invention, may be made without departing from the spirit and scope thereof. 

What is claimed is:
 1. A method of hyperpolarizing heteronuclei, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; and (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus.
 2. The method of claim 1, wherein the spin order is transferred during a temporary association of parahydrogen, the compound, and the catalyst while maintaining the chemical identity of the compound.
 3. The method of claim 1, wherein the resonance frequencies of parahydrogen and the at least one hyperpolarizable heteronucleus are different.
 4. The method of claim 1, wherein the magnetic field is determined by matching the resonance frequency of parahydrogen with the resonance frequency of at least one hyperpolarizable nucleus of the compound.
 5. The method of claim 1, wherein the magnetic field has a strength of less than 20 μT.
 6. The method of claim 1, wherein the magnetic field has a strength of about 0.1 to about 1 μT.
 7. The method of claim 1, wherein the at least one heteronucleus is selected from the group consisting of ³C, ¹⁵N, ¹⁹F, ²⁹Si, ³¹P, ²H and ²⁹Xe.
 8. The method of claim 1, wherein the at least one heteronucleus is ¹⁵N.
 9. The method of claim 1, wherein the mixture further comprises a solvent.
 10. The method of claim 9, wherein the solvent is a deuterated solvent.
 11. The method of claim 1, wherein the catalyst is a heterogeneous catalyst.
 12. The method of claim 1, wherein the catalyst is a homogeneous catalyst.
 13. The method of claim 1, wherein the catalyst comprises a transition metal.
 14. The method of claim 13, wherein the transition metal is iridium.
 15. The method of claim 1, wherein the catalyst is [IrCl(COD)(IMes)].
 16. The method of claim 1, wherein the catalyst is a homogeneous or heterogeneous catalyst, wherein the catalyst accommodates the simultaneous exchange of para-H₂ and heteronuclear spin center(s), and wherein the condition of spin-spin (weak or strong J) coupling between para-H₂ derived protons and heteronuclear spin center(s) is maintained.
 17. The method of claim 1, wherein the compound is isotopically enriched.
 18. The method of claim 1, wherein the compound is a contrast agent for an in vivo imaging technique.
 19. A method of performing an NMR experiment, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; and (c) performing an NMR measurement on the compound.
 20. A method of obtaining an MRI image, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; and (c) performing an MRI measurement or MR spectroscopy on the compound.
 21. A method of in vivo pH sensing, the method comprising: (a) combining parahydrogen, a compound comprising at least one hyperpolarizable heteronucleus, and a catalyst to form a mixture; wherein the compound has at least one pKa value of about 6 to about 9; (b) applying a magnetic field with a strength of less than 50 μT to the mixture, thereby transferring the spin order from parahydrogen to the at least one hyperpolarizable heteronucleus; (c) removing the catalyst from the mixture; and (d) performing an in vivo imaging measurement on the compound. 